LabCorp Tells Albright Not To Triple $272M IP Judgment

By Jasmin Boyce · October 20, 2022, 4:06 PM EDT

LabCorp has urged U.S. District Judge Alan Albright not to enhance a $272 million jury verdict against it in a biotechnology company's patent suit over a testing method for genetic disorders,...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Response

Case Information

Case Title

Ravgen, Inc. v. Laboratory Corporation of America Holdings

Case Number

Court

Texas Western

Nature of Suit

Patent

Date Filed

October 16, 2020

Recent Articles By Jasmin

July 21, 2023
Health Hires: Kleinfeld Kaplan, Michael Best, Creyon
July 18, 2023
Iowa Judge Halts 6-Week Abortion Ban Amid Challenge
July 14, 2023
Health Hires: Venable, McDermott, Arbutus
July 13, 2023
Gov't Takes 'No Surprises Act' Challenge To 5th Circ.
June 30, 2023
EU, Pfizer Strike Pandemic Prep Deal Via €5B Health Program
June 28, 2023
DOJ Targets Telehealth, Opioids In $2.5B Fraud Sweep
June 23, 2023
Health Hires: MapLight, Wilson Sonsini, Mayer Brown
June 21, 2023
Where State Abortion Ballot Measures Stand After Dobbs
June 16, 2023
Walgreens Must Face Bulk Of Kids' Cough Medicine Suit
June 06, 2023
Providers Challenge Kansas Abortion Restrictions